Bally, why would it be a buying opportunity if it falls to sub 12 or 10 cents. Wouldn't that mean either non FDA approval or the non venture partnership with a UK pharmacy chain will not go ahead, or the Chemist product launch in Australia will not proceed or a broker sell report comes out or their funds are drying up and another cap raising is on the cards e.t.c. Why would it be a buying opportunity at sub 10 or 12c ? What future prospects would there be? I wouldn't touch it. What this company needs is a progress report on the MD's current visit in UK to stop this current share price slide.
ISN Price at posting:
16.5¢ Sentiment: Hold Disclosure: Held
